Advanced in Neuroendocrine Tumor

Francois Benard

Vancouver, BC, CA 
Advanced in Neuroendocrine Tumor
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Francois Benard practices in Vancouver, Canada. Mr. Benard is rated as an Advanced expert by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Prostate Cancer, Cerebral Hypoxia, Neuroendocrine Tumor, Breast Cancer, and Prostatectomy.

His clinical research consists of co-authoring 255 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles and participated in 1 clinical trial in the study of Neuroendocrine Tumor.

Gender
Male

Locations

Vancouver, BC V6T2B5, Canada
Other Locations
Montreal, QC, Canada
2410 Lee Avenue, Victoria, BC V8R6V5, Canada
Vancouver, Canada
Ottawa, ON, Canada
3001, 12th Avenue North, J1H 5N4, Sherbrooke, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

68Ga-PSMA-11 Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of High Risk or Recurrent Prostate Cancer
68Ga-PSMA-11 Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of High Risk or Recurrent Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 09, 2025
Intervention Type: Drug
Phase II Study on the Role of the Positron Emission Tomography Combined With CT Scan for the Evaluation on Crohn Disease
Phase II Study on the Role of the Positron Emission Tomography Combined With CT Scan for the Evaluation on Crohn Disease
Enrollment Status: Completed
Publish Date: December 09, 2024
Intervention Type: Procedure
Study Phase: Phase 2
Fluorine-18 - 2-(3-(1-carboxy-5-[(6-[18F]Fluoro-pyridine-3-carbonyl)-Amino]-Pentyl)-Ureido)-Pentanedioic Acid (18F-DCFPyL) Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of Recurrent Prostate Cancer
Fluorine-18 - 2-(3-(1-carboxy-5-[(6-[18F]Fluoro-pyridine-3-carbonyl)-Amino]-Pentyl)-Ureido)-Pentanedioic Acid (18F-DCFPyL) Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of Recurrent Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2024
Intervention Type: Drug
Evaluation of Monosodium Glutamate (MSG) to Reduce Salivary Gland and Renal Accumulation of PSMA-binding Radiopharmaceuticals
Evaluation of Monosodium Glutamate (MSG) to Reduce Salivary Gland and Renal Accumulation of PSMA-binding Radiopharmaceuticals
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Diagnostic test
Study Phase: Not Applicable
[18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA) Positron Emission Tomography (PET) in Neuroendocrine Tumours
[18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA) Positron Emission Tomography (PET) in Neuroendocrine Tumours
Enrollment Status: No_longer_available
Publish Date: February 21, 2023
Intervention Type: Drug
A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients
A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Drug
Study Phase: Not Applicable
A Single-blind Study to Evaluate the Efficacy and Safety of 18F-Fluorodeoxygalactose (18F-FDGal) Compared to 18F-Fluorodeoxyglucose (18F-FDG) to Detect Hepatocellular Carcinoma Via PET/CT in Patients With Cirrhosis or Chronic Liver Disease
A Single-blind Study to Evaluate the Efficacy and Safety of 18F-Fluorodeoxygalactose (18F-FDGal) Compared to 18F-Fluorodeoxyglucose (18F-FDG) to Detect Hepatocellular Carcinoma Via PET/CT in Patients With Cirrhosis or Chronic Liver Disease
Enrollment Status: Withdrawn
Publish Date: February 21, 2023
Intervention Type: Drug
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
Enrollment Status: Terminated
Publish Date: February 17, 2022
Intervention Type: Drug, Procedure
Evaluation of the in Vivo Biodistribution and Radiation Dosimetry of 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
Evaluation of the in Vivo Biodistribution and Radiation Dosimetry of 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
Enrollment Status: Unknown
Publish Date: December 03, 2021
Intervention Type: Other
Study Phase: Not Applicable
View 8 Less Clinical Trials

255 Total Publications

Large Library Docking and Biophysical Analysis of Small-Molecule TMPRSS2 Inhibitors.
Large Library Docking and Biophysical Analysis of Small-Molecule TMPRSS2 Inhibitors.
Journal: Journal of medicinal chemistry
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Benard's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile